Scientists reveal atomic details for one of Legionella's enzymatic weapons and develop first inhibitor

May 24, 2018, Goethe University Frankfurt am Main
A detailed view of the 3D structure of the enzymatic active part of SdeA toxin (green). On the left, the essential catalytic surface is depicted in orange and the area for binding target proteins in purple. On the right, the amino acid residues involved in the reaction are highlighted. The detailed molecular picture now enables the design of suitable inhibitors. Credit: Nature/Kalayil et al, Mai 2018

Antimicrobial resistance (AMR) is a major medical problem worldwide, impacting both human health and economic well-being. A new strategy for fighting bacteria has now been reported in the latest online issue of Nature by a research group headed by Prof. Ivan Dikic at the Goethe University Frankfurt. The scientists revealed the molecular action mechanism of a Legionella toxin and developed a first inhibitor.

As resistance continues to spread, common infections such as pneumonia and salmonellosis are becoming increasingly harder to treat. Two factors drive the AMR crisis: human negligence in the use of antibiotics and a lack of truly novel antibiotics for more than 30 years. According to a recent report by the World Bank, by 2050, AMR may reduce the global gross domestic product by 1.1 percent to 3.8 percent, depending on which scenario plays out.

Scientific efforts are underway to achieve better control of microbial infections. One promising approach is to limit damage to host cells and tissues in the course of a by blocking the microbial processes that cause such damage. The laboratory of Ivan Dikic, Director of the Institute of Biochemistry II at Goethe University, has been working in this field for the past decade. Dikic says, "We believe we can find new treatments that complement conventional antibiotics by targeting specific groups of bacterial effectors with rationally designed drugs. In this way pathogenic damage can be decreased, which helps patients better tolerate bacterial infection. This is a relatively new field that is attracting more and more attention in the community."

To prove that this strategy is a viable option for tackling bacteria, Dikic's team studies Legionella, which are known to cause pneumonia and are especially dangerous for immunocompromised patients. Recently, the Frankfurt scientists were involved in identifying a novel enzymatic mechanism that Legionella bacteria use to seize control over their host cells. Dr. Sagar Bhogaraju, who works at Goethe University's Buchmann Institute for Molecular Life Sciences as part of the Dikic team, reports: "We showed that Legionella enzyme SdeA acts as a toxic bacterial effector. It promotes the spreading of bacteria by targeting the ubiquitin system, one of the cell's powerful protection mechanisms against stress."

Ivan Dikic's group has now reported a further breakthrough in the journal Nature: they succeeded in solving the atomic structure of SdeA. "The enzyme is truly unique and catalyses a reaction in a two-step mechanism," says Dr. Sissy Kalayil, who is one of the lead Frankfurt scientists on the project. "Our results are very exciting as they reveal atomic details of this mechanism, and make the rationale design of inhibitors possible."

In their publication, the researchers also reveal how this bacterial effector probably chooses its victim proteins within the host cell, exerting its effect by attaching ubiquitin to them. They also developed a first inhibitor blocking this reaction in vitro. "Our basic discovery has allowed us to prove that these enzymes are druggable," Dikic comments. "But it is early days. There is a long road ahead of us before we will be able to use this novel mechanism therapeutically. And we will surely not stop here." Most likely, Legionella is not the only bacterium using this .

Explore further: New chemistry of life: Novel ubiquitination mechanism explains pathogenic effects of Legionella infection

More information: Sissy Kalayil et al, Insights into catalysis and function of phosphoribosyl-linked serine ubiquitination, Nature (2018). DOI: 10.1038/s41586-018-0145-8

Related Stories

How cells combat salmonella

May 10, 2017

With drug resistance being on the rise worldwide, bacterial infections pose one of the greatest global threats to human health. By deciphering the host-pathogen interaction on a molecular level, researchers hope to pave the ...

Targeting key proteins of carcinogenesis

June 22, 2007

Misfolded and disused proteins are eliminated by a cellular shredder called the proteasome. The cell labels the proteins it wants to dispose with Ubiquitin (Ub) in order to avoid the unwanted degradation of still needed proteins. ...

Intestinal cell defense mechanism against bacteria

May 27, 2011

Salmonella is widely prevalent in the animal kingdom. The reason we do not suffer from severe intestinal infections very often is due to our body's defence system, which manages to digest invading bacteria. This is why, generally ...

Self-digestion as a means of survival

February 27, 2009

In times of starvation, cells tighten their belts: they start to digest their own proteins and cellular organs. The process - known as autophagy - takes place in special organelles called autophagosomes. It is a strategy ...

Recommended for you

After a reset, Сuriosity is operating normally

February 23, 2019

NASA's Curiosity rover is busy making new discoveries on Mars. The rover has been climbing Mount Sharp since 2014 and recently reached a clay region that may offer new clues about the ancient Martian environment's potential ...

Study: With Twitter, race of the messenger matters

February 23, 2019

When NFL player Colin Kaepernick took a knee during the national anthem to protest police brutality and racial injustice, the ensuing debate took traditional and social media by storm. University of Kansas researchers have ...

Researchers engineer a tougher fiber

February 22, 2019

North Carolina State University researchers have developed a fiber that combines the elasticity of rubber with the strength of a metal, resulting in a tougher material that could be incorporated into soft robotics, packaging ...

A quantum magnet with a topological twist

February 22, 2019

Taking their name from an intricate Japanese basket pattern, kagome magnets are thought to have electronic properties that could be valuable for future quantum devices and applications. Theories predict that some electrons ...

1 comment

Adjust slider to filter visible comments by rank

Display comments: newest first

humy
not rated yet May 24, 2018
I believe the currently massively underexploited phase therapy could also complement antibiotic use.
See;

https://en.wikipe..._therapy

Why isn't this already widely done?
Its just totally stupid not to.

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.